4.6 Article

Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures

期刊

CANCER GENE THERAPY
卷 17, 期 4, 页码 223-234

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/cgt.2009.73

关键词

extracellular matrix; vasculogenic mimicry; herpes simplex virus; oncolytic therapy; quiescence; Matrigel

资金

  1. Rosztoczy Foundation
  2. Public Health Service [EY10457]
  3. NATIONAL EYE INSTITUTE [R01EY010457] Funding Source: NIH RePORTER

向作者/读者索取更多资源

To better understand melanoma resistance to herpes simplex virus type 1 (HSV-1)-mediated oncolysis, traditional two-dimensional (2D) cultures and extracellular matrix (ECM) containing three-dimensional (3D) cultures of OCM1 and C918 uveal melanoma cells were infected with an HSV-1 strain that expresses the green fluorescent protein (GFP) marker during replication. Although 2D cultures were completely destroyed within a few days of HSV-1 inoculation, viable GFP-negative tumor cells remained detectable in 3D cultures for several weeks. Tumor cells with increased resistance to HSV-1 included cells that formed vasculogenic mimicry patterns and multicellular spheroids and cells that invaded Matrigel individually. Mechanisms of tumor resistance against HSV-1 in the 3D environment included impaired virus spread in the ECM and ECM-mediated inhibition of viral replication after viral entry into tumor cells. Observations also suggested that HSV-1 established quiescent infection in some tumor cells present in multicellular spheroids and that this could revert to productive viral infection when the tumor growth pattern changed. These findings indicate that 3D tumor cell cultures can be used to identify distinct tumor cell populations with increased resistance to HSV-1 and to explore mechanisms of ECM-mediated tumor resistance to oncolytic virotherapy. Cancer Gene Therapy (2010) 17, 223-234; doi: 10.1038/cgt.2009.73; published online 6 November 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据